Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of Virology|January 30, 2004
Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomasWen-hai Feng, Gregory Hong, Henri-Jacques Delecluse, et al.
Journal of Virology|September 24, 2010
The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsJillian A Bristol, Amanda R Robinson, Elizabeth A Barlow, et al.
Nature Genetics|September 14, 2004
The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genomePrasanna M Bhende, William T Seaman, Henri-Jacques Delecluse, et al.
Journal of Virology|May 28, 2005
BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186Prasanna M Bhende, William T Seaman, Henri-Jacques Delecluse, et al.
Journal of Virology|February 18, 2011
The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent mannerStacy R Hagemeier, Elizabeth A Barlow, Ariel A Kleman, et al.
Journal of Virology|December 23, 2016
Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus LatencyCoral K Wille, Yangguang Li, Lixin Rui, et al.
Cancer Research|March 26, 2002
Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumorsWen-hai Feng, Bruce Israel, Nancy Raab-Traub, et al.
The Journal of Biological Chemistry|August 3, 2004
The Epstein-Barr virus polymerase accessory factor BMRF1 adopts a ring-shaped structure as visualized by electron microscopyAlexander M Makhov, Deepa Subramanian, Elizabeth Holley-Guthrie, et al.
Pageof 9